Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride

M Pacilio, G Ventroni, G De Vincentis… - European journal of …, 2016 - Springer
Purpose Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castration-resistant prostate cancer. Image-based dosimetric studies …
被引用次数：141 相关文章

[引用][C] Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride

M Pacilio, G Ventroni, G De Vincentis… - European Journal of …, 2015 - cir.nii.ac.jp
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting^ sup 223^ Ra-dichloride

M Pacilio, G Ventroni, G De Vincentis… - … Journal of Nuclear …, 2016 - search.proquest.com
Purpose Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castration-resistant prostate cancer. Image-based dosimetric studies …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting" 2" 2" 3Ra-dichloride

M Pacilio, G Ventroni, L Mango… - European Journal of …, 2016 - inis.iaea.org
[en] Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of bone
metastases from castration-resistant prostate cancer. Image-based dosimetric studies …
[PDF] academia.edu

[PDF][PDF] Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223 Ra-dichloride

M Pacilio, G Ventroni, G De Vincentis, B Cassano… - academia.edu
Purpose Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castrationresistant prostate cancer. Image-based dosimetric studies …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223) Ra-dichloride.

M Pacilio, G Ventroni, G De Vincentis… - European Journal of …, 2015 - europepmc.org
Purpose Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castration-resistant prostate cancer. Image-based dosimetric studies …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting Ra-dichloride.

M Pacilio, G Ventroni, G De Vincentis… - … Journal of Nuclear …, 2016 - search.ebscohost.com
Purpose: Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castration-resistant prostate cancer. Image-based dosimetric studies …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223) Ra-dichloride

M Pacilio, G Ventroni, G De Vincentis… - … journal of nuclear …, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castration-resistant prostate cancer. Image-based dosimetric studies …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride

M Pacilio, G Ventroni, G De Vincentis… - European Journal of …, 2016 - infona.pl
Purpose Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of
bone metastases from castration-resistant prostate cancer. Image-based dosimetric studies …

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223) Ra-dichloride

M Pacilio, G Ventroni, G DE VINCENTIS… - EUROPEAN …, 2016 - iris.uniroma1.it
Ra-dichloride is an alpha-emitting radiopharmaceutical used in the treatment of bone
metastases from castration-resistant prostate cancer. Image-based dosimetric studies …